‘We need to be part of the solution’: lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies
On 25–26 April 2024, the 5th PPRI (Pharmaceutical Pricing and Reimbursement Information) Conference on ensuring equitable access to affordable medicines took place in Vienna (Austria). Twenty-four accepted contributions were presented either as oral presentations or posters, adding to invited keynot...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-04-01
|
| Series: | Journal of Pharmaceutical Policy and Practice |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20523211.2024.2442002 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832576256212729856 |
|---|---|
| author | Sabine Vogler Nina Zimmermann Verena Knoll Maximilian Salcher-Konrad Friederike Windisch Jaime Espin Aukje K. Mantel-Teeuwisse Dimitra Panteli Fatima Suleman Veronika J. Wirtz Zaheer-Ud-Din Babar |
| author_facet | Sabine Vogler Nina Zimmermann Verena Knoll Maximilian Salcher-Konrad Friederike Windisch Jaime Espin Aukje K. Mantel-Teeuwisse Dimitra Panteli Fatima Suleman Veronika J. Wirtz Zaheer-Ud-Din Babar |
| author_sort | Sabine Vogler |
| collection | DOAJ |
| description | On 25–26 April 2024, the 5th PPRI (Pharmaceutical Pricing and Reimbursement Information) Conference on ensuring equitable access to affordable medicines took place in Vienna (Austria). Twenty-four accepted contributions were presented either as oral presentations or posters, adding to invited keynote lectures, stakeholder debates and workshops. The global multi-stakeholder audience discussed a range of approaches in pharmaceutical policies, which have the potential to successfully and sustainably address current and future challenges in ensuring patient access to affordable medicines globally. These discussions benefited from the interaction between policy-makers, stakeholders in the private sector and researchers who provided evidence on implemented and piloted policies. Among the policy options that drew the most attention during the PPRI Conference were procurement with targeted instruments to achieve strategic objectives, innovative payment models such as different variants of managed-entry agreements, and new models to fund pharmaceutical research and development. Experiences on established policy options that are being newly introduced in several countries, such as price regulation, health technology assessment, evidence-based selection for reimbursement decisions and measures to enhance the uptake of biosimilar medicines were also shared. The PPRI Conference reaffirmed the relevance of pharmaceutical pricing, procurement and reimbursement policies aligned with policy actions in other areas and along the pharmaceutical life-cycle and emphasised the importance of developing needs-driven health systems. Innovation in policy-making is needed to work towards equitable patient access to affordable medicines. This requires transparency, alignment on evidence requirements, communication, coordination, intra-country and international collaboration, solidarity and trust. |
| format | Article |
| id | doaj-art-f78b1f3c5fb841b9a4e8beec2eee35f2 |
| institution | Kabale University |
| issn | 2052-3211 |
| language | English |
| publishDate | 2024-04-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Journal of Pharmaceutical Policy and Practice |
| spelling | doaj-art-f78b1f3c5fb841b9a4e8beec2eee35f22025-01-31T08:35:31ZengTaylor & Francis GroupJournal of Pharmaceutical Policy and Practice2052-32112024-04-0117sup110.1080/20523211.2024.2442002‘We need to be part of the solution’: lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policiesSabine Vogler0Nina Zimmermann1Verena Knoll2Maximilian Salcher-Konrad3Friederike Windisch4Jaime Espin5Aukje K. Mantel-Teeuwisse6Dimitra Panteli7Fatima Suleman8Veronika J. Wirtz9Zaheer-Ud-Din Babar10WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (Austrian National Public Health Institute), Vienna, AustriaQuality Management and Certification Department, Gesundheit Österreich GmbH (Austrian National Public Health Institute), Vienna, AustriaWHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (Austrian National Public Health Institute), Vienna, AustriaWHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (Austrian National Public Health Institute), Vienna, AustriaWHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (Austrian National Public Health Institute), Vienna, AustriaAndalusian School of Public Health, Granada, SpainWHO Collaborating Centre for Pharmaceutical Policy and Regulation, Utrecht University, Utrecht, the NetherlandsEuropean Observatory on Health Systems and Policies, Brussels, BelgiumWHO Collaborating Centre for Pharmaceutical Policy and Evidence Based Practice, School of Health Sciences, University of KwaZulu-Natal, Durban, South AfricaWHO Collaborating Center in Pharmaceutical Policy, Department of Global Health, Boston University School of Public Health, Boston, USACollege of Pharmacy, Qatar University, Doha, QatarOn 25–26 April 2024, the 5th PPRI (Pharmaceutical Pricing and Reimbursement Information) Conference on ensuring equitable access to affordable medicines took place in Vienna (Austria). Twenty-four accepted contributions were presented either as oral presentations or posters, adding to invited keynote lectures, stakeholder debates and workshops. The global multi-stakeholder audience discussed a range of approaches in pharmaceutical policies, which have the potential to successfully and sustainably address current and future challenges in ensuring patient access to affordable medicines globally. These discussions benefited from the interaction between policy-makers, stakeholders in the private sector and researchers who provided evidence on implemented and piloted policies. Among the policy options that drew the most attention during the PPRI Conference were procurement with targeted instruments to achieve strategic objectives, innovative payment models such as different variants of managed-entry agreements, and new models to fund pharmaceutical research and development. Experiences on established policy options that are being newly introduced in several countries, such as price regulation, health technology assessment, evidence-based selection for reimbursement decisions and measures to enhance the uptake of biosimilar medicines were also shared. The PPRI Conference reaffirmed the relevance of pharmaceutical pricing, procurement and reimbursement policies aligned with policy actions in other areas and along the pharmaceutical life-cycle and emphasised the importance of developing needs-driven health systems. Innovation in policy-making is needed to work towards equitable patient access to affordable medicines. This requires transparency, alignment on evidence requirements, communication, coordination, intra-country and international collaboration, solidarity and trust.https://www.tandfonline.com/doi/10.1080/20523211.2024.2442002Access to medicinespricetransparencyevidencecollaborationsolidarity |
| spellingShingle | Sabine Vogler Nina Zimmermann Verena Knoll Maximilian Salcher-Konrad Friederike Windisch Jaime Espin Aukje K. Mantel-Teeuwisse Dimitra Panteli Fatima Suleman Veronika J. Wirtz Zaheer-Ud-Din Babar ‘We need to be part of the solution’: lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies Journal of Pharmaceutical Policy and Practice Access to medicines price transparency evidence collaboration solidarity |
| title | ‘We need to be part of the solution’: lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies |
| title_full | ‘We need to be part of the solution’: lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies |
| title_fullStr | ‘We need to be part of the solution’: lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies |
| title_full_unstemmed | ‘We need to be part of the solution’: lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies |
| title_short | ‘We need to be part of the solution’: lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies |
| title_sort | we need to be part of the solution lessons from the 2024 ppri conference on ensuring access to affordable medicines through innovative policies |
| topic | Access to medicines price transparency evidence collaboration solidarity |
| url | https://www.tandfonline.com/doi/10.1080/20523211.2024.2442002 |
| work_keys_str_mv | AT sabinevogler weneedtobepartofthesolutionlessonsfromthe2024ppriconferenceonensuringaccesstoaffordablemedicinesthroughinnovativepolicies AT ninazimmermann weneedtobepartofthesolutionlessonsfromthe2024ppriconferenceonensuringaccesstoaffordablemedicinesthroughinnovativepolicies AT verenaknoll weneedtobepartofthesolutionlessonsfromthe2024ppriconferenceonensuringaccesstoaffordablemedicinesthroughinnovativepolicies AT maximiliansalcherkonrad weneedtobepartofthesolutionlessonsfromthe2024ppriconferenceonensuringaccesstoaffordablemedicinesthroughinnovativepolicies AT friederikewindisch weneedtobepartofthesolutionlessonsfromthe2024ppriconferenceonensuringaccesstoaffordablemedicinesthroughinnovativepolicies AT jaimeespin weneedtobepartofthesolutionlessonsfromthe2024ppriconferenceonensuringaccesstoaffordablemedicinesthroughinnovativepolicies AT aukjekmantelteeuwisse weneedtobepartofthesolutionlessonsfromthe2024ppriconferenceonensuringaccesstoaffordablemedicinesthroughinnovativepolicies AT dimitrapanteli weneedtobepartofthesolutionlessonsfromthe2024ppriconferenceonensuringaccesstoaffordablemedicinesthroughinnovativepolicies AT fatimasuleman weneedtobepartofthesolutionlessonsfromthe2024ppriconferenceonensuringaccesstoaffordablemedicinesthroughinnovativepolicies AT veronikajwirtz weneedtobepartofthesolutionlessonsfromthe2024ppriconferenceonensuringaccesstoaffordablemedicinesthroughinnovativepolicies AT zaheeruddinbabar weneedtobepartofthesolutionlessonsfromthe2024ppriconferenceonensuringaccesstoaffordablemedicinesthroughinnovativepolicies |